Texas 2025 89th Regular

Texas House Bill HB220 Comm Sub / Bill

Filed 04/15/2025

                    89R22703 MCF-F
 By: Ordaz, Orr, Rose, Frank, Howard, et al. H.B. No. 220
 Substitute the following for H.B. No. 220:
 By:  VanDeaver C.S.H.B. No. 220




 A BILL TO BE ENTITLED
 AN ACT
 relating to the care provided to sexual assault survivors by health
 care facilities.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 323.004, Health and Safety Code, is
 amended by amending Subsection (b) and adding Subsection (b-2) to
 read as follows:
 (b)  A health care facility providing care to a sexual
 assault survivor shall provide the survivor with:
 (1)  subject to Subsection (b-1), a forensic medical
 examination in accordance with Subchapter B, Chapter 420,
 Government Code, and Subchapter G, Chapter 56A, Code of Criminal
 Procedure;
 (2)  a private area, if available, to wait or speak with
 the appropriate medical, legal, or sexual assault crisis center
 staff or volunteer until a physician, nurse, or physician assistant
 is able to treat the survivor;
 (3)  access to a sexual assault program advocate, if
 available, as provided by Subchapter H, Chapter 56A, Code of
 Criminal Procedure;
 (4)  the information form required by Section 323.005;
 (5)  a private treatment room, if available;
 (6)  if indicated by the history of contact, access to
 appropriate prophylaxis for exposure to sexually transmitted
 infections;
 (7)  the name and telephone number of the nearest
 sexual assault crisis center; [and]
 (8)  if the health care facility has shower facilities,
 access to a shower at no cost to the survivor after the examination
 described by Subdivision (1); and
 (9)  if the survivor consents and the treatment is
 clinically indicated, an emergency contraceptive approved by the
 United States Food and Drug Administration to prevent pregnancy by
 delaying ovulation.
 (b-2)  A health care facility providing care to a sexual
 assault survivor may not provide or offer to provide the survivor
 with a drug or device that terminates a pregnancy.
 SECTION 2.  This Act takes effect September 1, 2025.